Viewing Study NCT07483359

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-06-30 @ 11:03 AM
Study NCT ID: NCT07483359
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-19
First Post: 2026-03-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus
Sponsor: First Hospital of China Medical University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma (HCC) View
None Portal Vein Tumor Thrombus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Conversion Therapy View
None Hepatic Arterial Infusion Chemotherapy View
None Tislelizumab View
None Lenvatinib View
None Vp3 Portal Vein Tumor Thrombus View